Central Trust Company’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $165K | Sell |
1,914
-375
| -16% | -$32.9K | ﹤0.01% | 655 |
|
|
2026
Q1 | $207K | Sell |
2,289
-125
| -5% | -$11.5K | ﹤0.01% | 588 |
|
|
2025
Q4 | $217K | Sell |
2,414
-320
| -12% | -$30.3K | ﹤0.01% | 568 |
|
|
2025
Q3 | $269K | Sell |
2,734
-80
| -3% | -$7.93K | 0.01% | 532 |
|
|
2025
Q2 | $257K | Sell |
2,814
-150
| -5% | -$14.5K | 0.01% | 525 |
|
|
2025
Q1 | $335K | Sell |
2,964
-14
| -0.5% | -$1.5K | 0.01% | 471 |
|
|
2024
Q4 | $315K | Hold |
2,978
| – | – | 0.01% | 486 |
|
|
2024
Q3 | $321K | Buy |
2,978
+73
| +3% | +$7.97K | 0.01% | 475 |
|
|
2024
Q2 | $315K | Sell |
2,905
-289
| -9% | -$34.1K | 0.01% | 479 |
|
|
2024
Q1 | $422K | Sell |
3,194
-221
| -6% | -$27.6K | 0.01% | 441 |
|
|
2023
Q4 | $416K | Buy |
3,415
+36
| +1% | +$4.02K | 0.01% | 428 |
|
|
2023
Q3 | $379K | Sell |
3,379
-221
| -6% | -$28.1K | 0.01% | 440 |
|
|
2023
Q2 | $524K | Sell |
3,600
-758
| -17% | -$103K | 0.01% | 409 |
|
|
2023
Q1 | $563K | Sell |
4,358
-1,822
| -29% | -$229K | 0.02% | 392 |
|
|
2022
Q4 | $788K | Hold |
6,180
| – | – | 0.02% | 332 |
|
|
2022
Q3 | $646K | Sell |
6,180
-200
| -3% | -$21.9K | 0.02% | 335 |
|
|
2022
Q2 | $671K | Hold |
6,380
| – | – | 0.02% | 341 |
|
|
2022
Q1 | $816K | Sell |
6,380
-347
| -5% | -$41.8K | 0.02% | 341 |
|
|
2021
Q4 | $830K | Sell |
6,727
-141
| -2% | -$18.5K | 0.02% | 352 |
|
|
2021
Q3 | $975K | Buy |
6,868
+124
| +2% | +$18.2K | 0.03% | 317 |
|
|
2021
Q2 | $1.05M | Sell |
6,744
-168
| -2% | -$27.2K | 0.04% | 300 |
|
|
2021
Q1 | $1.07M | Buy |
6,912
+67
| +1% | +$10.4K | 0.04% | 288 |
|
|
2020
Q4 | $1.02M | Sell |
6,845
-42
| -0.6% | -$5.93K | 0.04% | 274 |
|
|
2020
Q3 | $910K | Sell |
6,887
-49
| -0.7% | -$6.4K | 0.04% | 260 |
|
|
2020
Q2 | $804K | Sell |
6,936
-907
| -12% | -$105K | 0.04% | 265 |
|
|
2020
Q1 | $769K | Buy |
7,843
+339
| +5% | +$44.4K | 0.05% | 257 |
|
|
2019
Q4 | $1.09M | Sell |
7,504
-111
| -1% | -$15.3K | 0.06% | 249 |
|
|
2019
Q3 | $1.01M | Sell |
7,615
-15
| -0.2% | -$1.94K | 0.06% | 243 |
|
|
2019
Q2 | $897K | Sell |
7,630
-2,468
| -24% | -$289K | 0.05% | 251 |
|
|
2019
Q1 | $1.25M | Buy |
10,098
+5,474
| +118% | +$622K | 0.07% | 210 |
|
|
2018
Q4 | $465K | Sell |
4,624
-101
| -2% | -$11.4K | 0.03% | 315 |
|
|
2018
Q3 | $603K | Sell |
4,725
-154
| -3% | -$18.3K | 0.04% | 307 |
|
|
2018
Q2 | $528K | Sell |
4,879
-1,101
| -18% | -$120K | 0.03% | 326 |
|
|
2018
Q1 | $633K | Buy |
5,980
+41
| +0.7% | +$4.76K | 0.04% | 302 |
|
|
2017
Q4 | $696K | Sell |
5,939
-524
| -8% | -$59.3K | 0.04% | 296 |
|
|
2017
Q3 | $735K | Buy |
6,463
+1,009
| +19% | +$116K | 0.05% | 273 |
|
|
2017
Q2 | $680K | Buy |
5,454
+247
| +5% | +$29.3K | 0.05% | 280 |
|
|
2017
Q1 | $617K | Buy |
5,207
+598
| +13% | +$67.8K | 0.04% | 275 |
|
|
2016
Q4 | $462K | Sell |
4,609
-400
| -8% | -$42.9K | 0.03% | 306 |
|
|
2016
Q3 | $633K | Sell |
5,009
-51
| -1% | -$6.3K | 0.05% | 266 |
|
|
2016
Q2 | $592K | Buy |
5,060
+44
| +0.9% | +$4.98K | 0.04% | 276 |
|
|
2016
Q1 | $519K | Sell |
5,016
-41
| -0.8% | -$3.97K | 0.04% | 285 |
|
|
2015
Q4 | $504K | Sell |
5,057
-340
| -6% | -$33.3K | 0.04% | 282 |
|
|
2015
Q3 | $492K | Hold |
5,397
| – | – | 0.04% | 280 |
|
|
2015
Q2 | $572K | Sell |
5,397
-172
| -3% | -$19K | 0.05% | 283 |
|
|
2015
Q1 | $635K | Buy |
5,569
+957
| +21% | +$109K | 0.05% | 259 |
|
|
2014
Q4 | $507K | Buy |
4,612
+209
| +5% | +$22K | 0.04% | 293 |
|
|
2014
Q3 | $430K | Hold |
4,403
| – | – | 0.03% | 323 |
|
|
2014
Q2 | $443K | Buy |
4,403
+103
| +2% | +$10.1K | 0.03% | 320 |
|
|
2014
Q1 | $395K | Buy |
4,300
+839
| +24% | +$77.3K | 0.03% | 330 |
|
|
2013
Q4 | $314K | Sell |
3,461
-180
| -5% | -$15.6K | 0.03% | 363 |
|
|
2013
Q3 | $290K | Sell |
3,641
-103
| -3% | -$8.11K | 0.03% | 364 |
|
|
2013
Q2 | $272K | Buy |
+3,744
| New | +$280K | 0.03% | 349 |
|
Other funds holding ZBH
Central Trust Company's ZBH Position: Q2 2026 in Review
Central Trust Company reduced its Zimmer Biomet (ZBH) stake by 16% in Q2 2026, selling an estimated $32.9K and leaving 1,914 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #655.
Central Trust Company first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.25M in Q1 2019. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Central Trust Company held 1,914 shares of Zimmer Biomet worth $165K as of Q2 2026.
- Central Trust Company sold 375 Zimmer Biomet shares in Q2 2026, an estimated $32.9K.
- Zimmer Biomet made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #655 holding.
- Central Trust Company first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Central Trust Company's Zimmer Biomet position peaked at $1.25M in Q1 2019.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.